Previous studies have shown that ELK1 phosphorylation can be modulated in various central nervous system diseases (CNS diseases), such as Alzheimer’s’ disease, Huntington’s disease, Down syndrome and depression (Besnard et al., 2011; Demir et al., 2011). This evidence concerns the gene ELK1 and major depressive disorder.